Aplus Biotechnology Corporation Limited (6918.TWO)

TWD 81.0

(-3.57%)

Market Cap (In TWD)

2.44 Billion

Revenue (In TWD)

675.04 Million

Net Income (In TWD)

31.15 Million

Avg. Volume

74.45 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
43.85-96.9
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006918006
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Healthcare
CEO
-
Employee Count
-
Website
https://www.aplusbio.com
Ipo Date
2023-01-06
Details
Aplus Biotechnology Corporation Limited engages in the development of orthopedic trauma medical equipment products. The company is based in New Taipei City, Taiwan.